Artículos por temáticas

One central oscillatory drive is compatible with experimental motor unit behaviour in essential and Parkinsonian tremor.

Dideriksen JL, Gallego JA, Holobar A, Rocon E, Pons JL, Farina D.

J Neural Eng. 2015 Aug;12(4):046019. doi: 10.1088/1741-2560/12/4/046019.

Sustained Effects of a Neural-based Intervention in a Refractory Case of Tourette Syndrome.

Carvalho S, Gonçalves ÓF, Soares JM, Sampaio A, Macedo F, Fregni F, Leite J.

Brain Stimul. 2015 May-Jun;8(3):657-9. doi: 10.1016/j.brs.2014.12.008. No abstract available.

Pathological findings of anti-Yo cerebellar degeneration with Holmes tremor.

Rydz D, Lin CY, Xie T, Cortes E, Vonsattel JP, Kuo SH.

J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):121-2. doi: 10.1136/jnnp-2014-308074. No abstract available.

TORC1 Inhibition by Rapamycin Promotes Antioxidant Defences in a Drosophila Model of Friedreich's Ataxia.

Calap-Quintana P, Soriano S, Llorens JV, Al-Ramahi I, Botas J, Moltó MD, Martínez-Sebastián MJ.

PLoS One. 2015 Jul 9;10(7):e0132376. doi: 10.1371/journal.pone.0132376.

A comparison of montreal cognitive assessment between patients with visual hallucinations and without visual hallucinations in Parkinson's disease.

Chung EJ, Seok K, Kim SJ.

Clin Neurol Neurosurg. 2015 Mar;130:98-100. doi: 10.1016/j.clineuro.2014.12.022.

A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia.

Anjomani Virmouni S, Ezzatizadeh V, Sandi C, Sandi M, Al-Mahdawi S, Chutake Y, Pook MA.

Dis Model Mech. 2015 Mar;8(3):225-35. doi: 10.1242/dmm.018952.

Long-term cognitive follow-up of Parkinson's disease patients with impulse control disorders.

Siri C, Cilia R, Reali E, Pozzi B, Cereda E, Colombo A, Meucci N, Canesi M, Zecchinelli AL, Tesei S, Mariani CB, Sacilotto G, Zini M, Pezzoli G.

Mov Disord. 2015 Apr 15;30(5):696-704. doi: 10.1002/mds.26160.

Dietary factors in the etiology of Parkinson's disease.

Agim ZS, Cannon JR.

Biomed Res Int. 2015;2015:672838. doi: 10.1155/2015/672838. Review.

Treatment for dysphagia (swallowing difficulties) in hereditary ataxia.

Vogel AP, Keage MJ, Johansson K, Schalling E.

Cochrane Database Syst Rev. 2015 Nov 13;(11):CD010169. doi: 10.1002/14651858.CD010169.pub2. Review.

Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.

Iderberg H, McCreary AC, Varney MA, Cenci MA, Newman-Tancredi A.

Neuropharmacology. 2015 Jun;93:52-67. doi: 10.1016/j.neuropharm.2015.01.012.

Prevalence and correlates of sleep disorders in Parkinson's disease: a polysomnographic study.

Alatriste-Booth V, Rodríguez-Violante M, Camacho-Ordoñez A, Cervantes-Arriaga A.

Arq Neuropsiquiatr. 2015 Mar;73(3):241-5. doi: 10.1590/0004-282X20140228.

Dynamics of the connectome in Huntington's disease: A longitudinal diffusion MRI study.

Odish OF, Caeyenberghs K, Hosseini H, van den Bogaard SJ, Roos RA, Leemans A.

Neuroimage Clin. 2015 Jul 31;9:32-43. doi: 10.1016/j.nicl.2015.07.003.

Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington's disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number.

Rossignol J, Fink KD, Crane AT, Davis KK, Bombard MC, Clerc S, Bavar AM, Lowrance SA, Song C, Witte S, Lescaudron L, Dunbar GL.

Stem Cell Res Ther. 2015 Feb 19;6:9. doi: 10.1186/scrt545.

Large Animal Models of Huntington's Disease.

Li XJ, Li S.

Curr Top Behav Neurosci. 2015;22:149-60. doi: 10.1007/7854_2013_246. Review.

Linking microtubules to Parkinson's disease: the case of parkin.

Cappelletti G, Casagrande F, Calogero A, De Gregorio C, Pezzoli G, Cartelli D.

Biochem Soc Trans. 2015 Apr;43(2):292-6. doi: 10.1042/BST20150007. Review.